Literature DB >> 31691183

White Matter Abnormalities Linked to Interferon, Stress Response, and Energy Metabolism Gene Expression Changes in Older HIV-Positive Patients on Antiretroviral Therapy.

Isaac H Solomon1,2, Sukrutha Chettimada2, Vikas Misra2, David R Lorenz2, Robert J Gorelick3, Benjamin B Gelman4, Susan Morgello5, Dana Gabuzda6,7.   

Abstract

Neurocognitive impairment (NCI) remains a significant cause of morbidity in human immunodeficiency virus (HIV)-positive individuals despite highly active antiretroviral therapy (HAART). White matter abnormalities have emerged as a key component of age-related neurodegeneration, and accumulating evidence suggests they play a role in HIV-associated neurocognitive disorders. Viral persistence in the brain induces chronic inflammation associated with lymphocytic infiltration, microglial proliferation, myelin loss, and cerebrovascular lesions. In this study, gene expression profiling was performed on frontal white matter from 34 older HIV+ individuals on HAART (18 with NCI) and 24 HIV-negative controls. We used the NanoString nCounter platform to evaluate 933 probes targeting inflammation, interferon and stress responses, energy metabolism, and central nervous system-related genes. Viral loads were measured using single-copy assays. Compared to HIV- controls, HIV+ individuals exhibited increased expression of genes related to interferon, MHC-1, and stress responses, myeloid cells, and T cells and decreased expression of genes associated with oligodendrocytes and energy metabolism in white matter. These findings correlated with increased white matter inflammation and myelin pallor, suggesting interferon (IRFs, IFITM1, ISG15, MX1, OAS3) and stress response (ATF4, XBP1, CHOP, CASP1, WARS) gene expression changes are associated with decreased energy metabolism (SREBF1, SREBF2, PARK2, TXNIP) and oligodendrocyte myelin production (MAG, MOG), leading to white matter dysfunction. Machine learning identified a 15-gene signature predictive of HIV status that was validated in an independent cohort. No specific gene expression patterns were associated with NCI. These findings suggest therapies that decrease chronic inflammation while protecting mitochondrial function may help to preserve white matter integrity in older HIV+ individuals.

Entities:  

Keywords:  Aging; HIV-associated neurocognitive disorders; Inflammation; Interferon response; Oxidative stress; Stress response; White matter

Mesh:

Substances:

Year:  2019        PMID: 31691183      PMCID: PMC7035207          DOI: 10.1007/s12035-019-01795-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  60 in total

1.  Missing value estimation methods for DNA microarrays.

Authors:  O Troyanskaya; M Cantor; G Sherlock; P Brown; T Hastie; R Tibshirani; D Botstein; R B Altman
Journal:  Bioinformatics       Date:  2001-06       Impact factor: 6.937

2.  Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy.

Authors:  I Everall; F Vaida; N Khanlou; D Lazzaretto; C Achim; S Letendre; D Moore; R Ellis; M Cherner; B Gelman; S Morgello; E Singer; I Grant; E Masliah
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

3.  The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease.

Authors:  S Morgello; B B Gelman; P B Kozlowski; H V Vinters; E Masliah; M Cornford; W Cavert; C Marra; I Grant; E J Singer
Journal:  Neuropathol Appl Neurobiol       Date:  2001-08       Impact factor: 8.090

4.  An augmented aging process in brain white matter in HIV.

Authors:  Taylor Kuhn; Tobias Kaufmann; Nhat Trung Doan; Lars T Westlye; Jacob Jones; Rodolfo A Nunez; Susan Y Bookheimer; Elyse J Singer; Charles H Hinkin; April D Thames
Journal:  Hum Brain Mapp       Date:  2018-02-27       Impact factor: 5.038

Review 5.  Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.

Authors:  Sanaz Nasoohi; Saifudeen Ismael; Tauheed Ishrat
Journal:  Mol Neurobiol       Date:  2018-02-27       Impact factor: 5.590

6.  Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.

Authors:  Gustaf Ulfhammer; Arvid Edén; Åsa Mellgren; Dietmar Fuchs; Henrik Zetterberg; Lars Hagberg; Staffan Nilsson; Aylin Yilmaz; Magnus Gisslén
Journal:  AIDS       Date:  2018-09-24       Impact factor: 4.177

7.  IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP.

Authors:  K L Jønsson; A Laustsen; C Krapp; K A Skipper; K Thavachelvam; D Hotter; J H Egedal; M Kjolby; P Mohammadi; T Prabakaran; L K Sørensen; C Sun; S B Jensen; C K Holm; R J Lebbink; M Johannsen; M Nyegaard; J G Mikkelsen; F Kirchhoff; S R Paludan; M R Jakobsen
Journal:  Nat Commun       Date:  2017-02-10       Impact factor: 14.919

8.  Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy.

Authors:  Allen Ko; Guobin Kang; Julian B Hattler; Hadiza I Galadima; Junfeng Zhang; Qingsheng Li; Woong-Ki Kim
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-07       Impact factor: 4.147

9.  Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis.

Authors:  Rhonda R Voskuhl; Noriko Itoh; Alessia Tassoni; Macy Akiyo Matsukawa; Emily Ren; Vincent Tse; Ellis Jang; Timothy Takazo Suen; Yuichiro Itoh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-30       Impact factor: 11.205

Review 10.  HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.

Authors:  Christian Eggers; Gabriele Arendt; Katrin Hahn; Ingo W Husstedt; Matthias Maschke; Eva Neuen-Jacob; Mark Obermann; Thorsten Rosenkranz; Eva Schielke; Elmar Straube
Journal:  J Neurol       Date:  2017-05-31       Impact factor: 4.849

View more
  6 in total

1.  Inhibitors of Myelination and Remyelination, Bone Morphogenetic Proteins, are Upregulated in Human Neurological Disease.

Authors:  Judith B Grinspan
Journal:  Neurochem Res       Date:  2020-02-06       Impact factor: 3.996

Review 2.  Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program.

Authors:  Patricia K Riggs; Antoine Chaillon; Guochun Jiang; Scott L Letendre; Yuyang Tang; Jeff Taylor; Andrew Kaytes; Davey M Smith; Karine Dubé; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-19       Impact factor: 5.495

Review 3.  Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders.

Authors:  Elena Irollo; Jared Luchetta; Chunta Ho; Bradley Nash; Olimpia Meucci
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

4.  HIV-induced neuroinflammation inhibits oligodendrocyte maturation via glutamate-dependent activation of the PERK arm of the integrated stress response.

Authors:  Lindsay M Roth; Cagla Akay-Espinoza; Judith B Grinspan; Kelly L Jordan-Sciutto
Journal:  Glia       Date:  2021-05-31       Impact factor: 8.073

5.  Differential effects of integrase strand transfer inhibitors, elvitegravir and raltegravir, on oligodendrocyte maturation: A role for the integrated stress response.

Authors:  Lindsay M Roth; Bassam Zidane; Lindsay Festa; Raj Putatunda; Micah Romer; Hubert Monnerie; Kelly L Jordan-Sciutto; Judith B Grinspan
Journal:  Glia       Date:  2020-09-07       Impact factor: 7.452

6.  Neuroinflammation and EIF2 Signaling Persist despite Antiretroviral Treatment in an hiPSC Tri-culture Model of HIV Infection.

Authors:  Sean K Ryan; Michael V Gonzalez; James P Garifallou; Frederick C Bennett; Kimberly S Williams; Nathaniel P Sotuyo; Eugene Mironets; Kieona Cook; Hakon Hakonarson; Stewart A Anderson; Kelly L Jordan-Sciutto
Journal:  Stem Cell Reports       Date:  2020-03-26       Impact factor: 7.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.